Skip to main content

Donor_Supported_Research News

William Tansey Researchers putting the brakes on lethal childhood cancer

A recent study suggests that blocking the MYC protein could be “unexpectedly effective” in treating malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers.

Friday, May 3rd, 2019
VICC Ambassadors 2019 Cancer Center Ambassadors surpass $1 million in grants
Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.
Friday, March 15th, 2019
Ashley Larcinese Cancer fight personal for VICC Ambassadors chair
As this year’s chair of the VICC Ambassadors, Ashley Larcinese, is driven by her experiences to see that research is funded at VICC.
Saturday, December 1st, 2018
Charles Caskey Mary Kay Foundation grant to bolster immunotherapy research
Charles Caskey, Ph.D., has received a cancer research grant from The Mary Kay Foundation to study how focused ultrasound therapy could be an ideal helper for immunotherapy.
Monday, October 22nd, 2018
BlackHawk donation Entertainers’ support strengthens VICC melanoma research efforts

Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research.

Friday, April 13th, 2018
Justin Balko Study seeks to boost breast tumor immune response

Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications.

Thursday, February 8th, 2018
glutamine structure VUMC researchers find a way to ‘starve’ cancer

Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.

Thursday, January 18th, 2018
medical samples Liquid biopsies help reveal lung cancer mutations

Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC)

Thursday, November 2nd, 2017
ovarian cancer ribbon Chic Awearness event supports VUMC ovarian cancer research

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:

Sunday, September 17th, 2017
antibodies monoclonal HDAC3 role in B-cell development

Histone deacetylases (HDACs) are enzymes that modulate gene expression and have important roles in development and disease. HDAC inhibitors are active against lymphoma, and understanding the roles of specific HDACs is important for further therapeutic development. Scott Hiebert, Ph.

Monday, August 7th, 2017
Jonathan Irish Investigators seek new way to define cell identity
Jonathan Irish, Ph.D., and colleagues have developed a new way to describe and identify cells.
Monday, March 6th, 2017